Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 744.05
+17.85 (2.46%)
Jan 22, 2026, 11:10 AM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 58.45 billion as of January 21, 2026. Its market cap has decreased by -6.81% in one year.
Market Cap
58.45B
Enterprise Value
57.47B
Revenue
7.15B
Ranking
n/a
PE Ratio
32.00
Stock Price
744.05
Market Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 58.45B, an increase of 85.80%. That is a compound annual growth rate of 16.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 58.45B | -3.37% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.00T |
| Divi's Laboratories | 1.66T |
| Cipla | 1.12T |
| Apollo Hospitals Enterprise | 1.03T |
| Mankind Pharma | 898.02B |
| Zydus Lifesciences | 873.51B |
| Alkem Laboratories | 697.84B |
| Aurobindo Pharma | 681.11B |